Gene: EDNRA
Official Full Name: endothelin receptor type Aprovided by HGNC
Gene Summary: This gene encodes the receptor for endothelin-1, a peptide that plays a role in potent and long-lasting vasoconstriction. This receptor associates with guanine-nucleotide-binding (G) proteins, and this coupling activates a phosphatidylinositol-calcium second messenger system. Polymorphisms in this gene have been linked to migraine headache resistance. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08080 | EDNRA Knockout cell line (HCT 116) | Human | EDNRA | 1:2~1:4 | Negative | Online Inquiry |
KO08081 | EDNRA Knockout cell line (HEK293) | Human | EDNRA | 1:3~1:6 | Negative | Online Inquiry |
EDNRA Gene Knockout Cell Lines are genetically engineered cell lines designed to specifically disrupt the expression of the endothelin receptor type A (EDNRA) gene. These cell lines are invaluable tools for researchers studying the physiological and pathological roles of the endothelin signaling pathway, particularly in vascular biology, cardiovascular diseases, and cancer. By silencing the EDNRA gene, these knockout cell lines allow for the analysis of downstream signaling effects and help elucidate the biological functions of endothelins in various cellular contexts.
The key function of EDNRA Gene Knockout Cell Lines lies in their ability to provide a controlled model for investigating the consequences of losing EDNRA expression. The mechanism involves CRISPR/Cas9 gene editing technology, which ensures precise modifications of the target genome, leading to the complete knockout of the EDNRA gene. This facilitates studies on how disruption of endothelin signaling influences cellular behaviors, such as proliferation, migration, and apoptosis, which are critical in both normal physiology and disease.
The scientific importance of these cell lines extends to their applications in basic and translational research. In vascular biology, they are essential for dissecting the role of endothelin in vascular tone regulation. In cancer research, EDNRA knockout models can help clarify the receptor's role in tumor progression and metastasis. Additionally, these cell lines can significantly contribute to drug discovery efforts targeting the endothelin pathway.
EDNRA Gene Knockout Cell Lines offer several advantages over traditional methods, such as pharmacological inhibition or overexpression systems. By providing a stable, well-characterized genetic background, they ensure consistent and reproducible results that reflect physiological conditions more accurately. Furthermore, these knockout lines eliminate off-target effects and variability associated with chemical inhibitors, making them a superior choice for rigorous research.
For researchers and clinicians aiming to deepen their understanding of endothelin-mediated processes, the EDNRA Gene Knockout Cell Lines present a valuable resource that promises to yield robust data and insights. The precision and reliability of these models facilitate groundbreaking discoveries in understanding both health and disease states.
Our company specializes in providing high-quality biological products backed by extensive scientific expertise and rigorous quality control. We are committed to empowering researchers with the tools they need to advance their studies and contribute to significant scientific advancements.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.